How many people live with a given rare disease? How many more remain undiagnosed? Can we develop a formula to predict improvement in diagnosis rates across diseases? A recent article by the International Society for Pharmacoeconomics and Outcomes Research attempts to answer these riddles.
The Rare Collective partners with industry to guide the efficient development, commercialization and adoption of innovative therapies and devices for the rare disease communities they serve.Learn More